Chronic kidney disease, stage 3 unspecified
ICD-10 N18.30 is a billable code used to indicate a diagnosis of chronic kidney disease, stage 3 unspecified.
Chronic kidney disease (CKD) stage 3 is characterized by a moderate decrease in kidney function, with an estimated glomerular filtration rate (eGFR) ranging from 30 to 59 mL/min/1.73 m². This stage is often asymptomatic but can lead to complications such as hypertension, anemia, and bone disease. Patients may experience fatigue, swelling, and changes in urination patterns. Management typically includes controlling blood pressure, managing diabetes, and dietary modifications. Regular monitoring of kidney function is essential to assess progression to more advanced stages of CKD or the potential need for renal replacement therapy, including dialysis or transplantation. The unspecified designation indicates that the specific cause of CKD is not documented, which can complicate treatment planning and prognosis. Understanding the nuances of CKD staging is crucial for appropriate coding and management.
Detailed history of kidney function, eGFR results, and treatment plans.
Management of patients with CKD, monitoring progression, and planning for dialysis or transplant.
Ensure accurate staging of CKD and documentation of any complications or co-morbidities.
Routine monitoring of kidney function, management of hypertension and diabetes.
Screening for CKD in at-risk populations, managing chronic conditions that affect kidney health.
Documenting risk factors and patient education on CKD management.
Used for patients with advanced CKD requiring renal replacement therapy.
Document the frequency and duration of dialysis sessions.
Nephrology specialists should ensure accurate coding based on treatment plans.
CKD stage 3 indicates moderate kidney damage and a significant risk for progression to end-stage renal disease. It requires careful monitoring and management to prevent complications.
